Cynosure Lutronic has launched the XERF monopolar radiofrequency platform in Europe, positioning it as a next-generation solution for non-invasive skin tightening. Monopolar RF—which delivers energy between a single electrode and a dispersive pad—has become a workhorse modality for facial and body tightening, competing directly against microfocused ultrasound (SMAS-level depth) and fractional CO2 for laxity correction.
Devices & Tech
Cynosure Lutronic Launches XERF Monopolar RF Platform in Europe
A new monopolar RF system enters the European market as non-invasive skin tightening demand accelerates.
1-YEAR MOVE
INMD
▲1.0%
| Ticker | Company | 1-year change |
|---|---|---|
| INMD | InMode Ltd. | +1.0% |
Cynosure's XERF monopolar RF enters Europe as patient demand for non-invasive skin tightening accelerates.
The XERF entry reflects Cynosure's strategy to expand its RF footprint beyond the existing Cutera and InMode platforms already established in European practices. Monopolar RF's appeal lies in predictable depth penetration, lower operator variability than microneedling RF, and established safety data. However, European adoption depends on reimbursement clarity (varies by country), capital acquisition cost relative to competing platforms, and clinical outcomes data. The device will compete against entrenched players offering similar modalities at established price points.
Source: original report ↗
Frequently asked questions
What is monopolar RF and how does it differ from other radiofrequency devices?
Monopolar RF delivers energy between a single electrode and a dispersive pad, enabling predictable depth penetration with lower operator variability than microneedling RF systems. It competes directly against microfocused ultrasound and fractional CO2 for non-invasive skin tightening and facial laxity correction.
What is the XERF platform and who makes it?
XERF is a monopolar radiofrequency platform recently launched by Cynosure Lutronic in Europe. It represents the company's expansion of its RF footprint beyond existing Cutera and InMode platforms already in use across European practices.
Why is monopolar RF becoming popular for skin tightening?
Monopolar RF offers predictable depth penetration, established safety data, and lower operator variability compared to microneedling RF alternatives. These factors make it a reliable workhorse modality for both facial and body tightening treatments.
What factors will determine XERF adoption in European med spas?
European adoption will depend on reimbursement clarity (which varies by country), capital acquisition cost relative to competing platforms, and clinical outcomes data. The device must compete against entrenched players offering similar modalities at established price points.
How does monopolar RF compare to microfocused ultrasound for skin tightening?
Both monopolar RF and microfocused ultrasound target SMAS-level depth for non-invasive skin tightening, but monopolar RF offers more predictable depth penetration and lower operator variability. The choice between them often depends on practice preference, patient candidacy, and reimbursement availability.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.